Becoming waivered
Description:
The Substance Abuse and Mental Health Services Administration (SAMHSA) provides this website so that physicians can improve the deliver and financing of prevention, treatment and recovery support services to patients.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA)
Tags:
- General information - opioid addiction
- General information - buprenorphine
- Screening and diagnosis
- Induction and dosing
- Rules, regulations and recordkeeping
- Physician and staff training
- Addiction
- Adolescents
- Dependence
- Pharmacotherapy
- Screening
- Side effects
- Tolerance
- Withdrawal
- Misc. informational materials
- Patient education materials
- Becoming waivered
- Experienced prescriber
- Just became waivered
- Need to refer
- Setting up a practice
Description:
The California Society of Addiction Medicine (CSAM) website provides information and materials for buprenorphine treatment providers, including screening tools and sample consent and patient agreement forms, and provides links to other helpful resources.
Source:
California Society of Addiction Medicine (CSAM)
Tags:
- General information - buprenorphine
- Getting a waiver/setting up your practice
- Initial patient contact
- Screening and diagnosis
- Rules, regulations and recordkeeping
- Physician and staff training
- Addiction
- Assessment
- Confidentiality
- Consent
- Contract
- COWS
- Recordkeeping
- Screening
- Training
- Waiver
- Misc. informational materials
- Becoming waivered
- Just became waivered
- Need to refer
- Setting up a practice
Description:
PCSS-B is a free mentoring service funded by SAMHSA and coordinated by ASAM. The PCSS-B can match you with a physician mentor from your local area with whom you can discuss practice and treatment issues with him/her.
Source:
Physician Clinical Support System (PCSS)
Tags:
Description:
This book presents an historical overview of heroin use in the USA, as well as articles by experts in the field which focus on current developments and emerging trends in prevention, treatment, distribution and consumption. Filling a void in the literature on what is known about the `new' heroin users, this volume also updates the reader on the status of aging heroin-addicted populations who initiated use of the drug prior to the `age of cocaine'.
Source:
SAGE Publications
Tags:
Description:
This clinical guidance provides information about the requirements for storing, dispensing, and maintaining records for physicians who provide office-based opioid treatment.
Source:
Physician Clinical Support System (PCSS)
Tags:
Description:
Buprenorphine tablets are approved for the treatment of opiate dependence. Buprenorphine treats opiate addiction by preventing symptoms of withdrawal from heroin and other opiates.
Source:
Food and Drug Administration (FDA)
Tags:
Description:
Information from the CSAT Buprenorphine Information Center on the criteria required to receive waiver under DATA 2000.
Source:
CSAT Buprenorphine Information Center
Tags:
Description:
This document discusses the logistics of successful buprenorphine induction, offering insight into clinical questions that should be addressed, the goal of induction, general principles, and recommendations based on low and high levels of evidence. Recommendations are included for both in-office and at-home inductions.
Source:
Physician Clinical Support System (PCSS) (3 votes)
Tags:
Description:
This 2007 video segment from CBS News discusses the widespread problem of prescription drug dependence and how buprenorphine can help.
Source:
CBS News (2 votes)
Tags:
Description:
This 2006 document explains the Drug Enforcement Agency's (DEA) role in regulation of controlled substances and the physician's legal responsibility to prescribe controlled substances for legitimate medical purposes.
Source:
Drug Enforcement Agency (DEA) (4 votes)
Tags:
